መነሻ › Sickle Cell በሽታ › አላባማ
በአላባማ ለSickle Cell በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለSickle Cell በሽታ የሚደረጉ 16 ጥናቶች በአላባማ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአላባማ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University Of Alabama, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ12 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Uni of Alabama at Birmingham, Birmingham
- Univer South Alabama Ped/Onc, Mobile
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- University of Alabama Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ12 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06546670SCD Stem Cell Mobilization and Apheresis Using Motixafortide
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06442761A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- AMR Clinical, Mobile
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT05431088The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ10 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06975865Early Life Exposures Among Children With Sickle Cell Disease
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 50 · ሴቶች · የተሻሻለው በ15 ጁላይ 2026 · NCT05377372Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- University Of Alabama, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 4
6 Months – 100 Years · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁን 2026 · NCT04657822Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ3 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06941389Cognitive Remediation Intervention to Prepare for Transition of Care
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ10 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ27 ፌብሩ 2026 · NCT05336201A Long-term Follow-up Study in Patients Who Received BEAM-101
- University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ14 እስከ 37 · ሁሉም ጾታዎች · የተሻሻለው በ28 ጃንዩ 2026 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- University of South Alabama Medical Center, Mobile
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ16 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ7 ጃንዩ 2026 · NCT06374238HPC Offered for PRESERVE Expansion
- University of Alabama, Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ12 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2025 · NCT07145411Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Alabama, Birmingham (UAB), Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2025 · NCT06385886ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።